$CRDL News
Last published 1mo ago
- 1mo agoCRDLCardiol Therapeutics Phase III MAVERIC Trial. Why Fewer Recurrences Led to More Patients - CARDIOL THERAPEUTICS INCEarnings Call TranscriptsCardiolRx is targeting inflammation importantly in a non-immune suppressing way with really an extraordinary safety profile. For developing a new drug that is accessible to the masses that are affected by the disease, th
- 1mo agoCRDLFEWER EPISODES OF RECURRENCE, SO WHY EXPAND THIS HEART DRUG TRIAL? | DAVID ELSLEY - CARDIOL - CARDIOL THERAPEUTICS INCEarnings Call TranscriptsGood afternoon, everyone. Today, we're taking a break from mining and chatting with biotech. I'm joined with David Elsley, president and CEO of Cardiol Therapeutics. CardiOL is developing CardiL-RX, an oral anti-inflamma
- 1mo agoCRDLELLIS MARTIN REPORT: CARDIOL THERAPEUTICS CEO DAVID ELSLEY:PHASE III MAVERIC - WHAT COMES NEXT $CRDL - CARDIOL THERAPEUTICS INCEarnings Call TranscriptsWelcome to the Ellis Martin Report and Money Talk Radio. I'm Ellis Martin. Today we're speaking with David Elsley, President and CEO of Cardio Therapeutics. Cardio Therapetics trades on the NASDAQ and the TSX under the s
- 1mo agoCRDLCardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial to Strengthen Assessment of CardiolRx™'s EfficacyPR NewswireCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and ...
- 1mo agoCRDLCardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in ProceedsPR NewswireCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and ...
- 2mo agoCRDLCardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Including Additional Disclosure Following Review by Staff of the Ontario Securities CommissionPR NewswireCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and ...
- 2mo agoCRDLCardiol Therapeutics to Participate in a Fireside Chat at the H.C. Wainwright 28th Annual Global Investment ConferencePR NewswireCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and ...
- 3mo agoCRDLCG 46TH ANNUAL GROWTH CONFERENCE - CARDIOL THERAPEUTICS INCEarnings Call TranscriptsHi, good morning everyone. My name is Edward Nash. I'm a senior analyst here at Canaccord Genuity on the biotech research team. I have the pleasure of welcoming the management team of Cardiol Therapeutics with us today.
- 3mo agoCRDLCardiol Therapeutics to Participate in Fireside Chat at Canaccord Genuity's 46th Annual Growth ConferencePR NewswireCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and ...
- 4mo agoCRDLCardiol Therapeutics' Phase II Recurrent Pericarditis Data Published in the Journal of the American Heart AssociationPR NewswireCardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences company advancing anti-inflammatory and ...
- 4mo agoCRDLCardiol Therapeutics to Participate in Fireside Chat at B. Riley Securities Mind, Muscle & Vision SummitPR NewswireTORONTO, July 9, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences...
- 4mo agoCRDLKOL Webcast with Paul Cremer M.D. - Canaccord Genuity, LLCEarnings Call TranscriptsGood morning to everyone and thank you for joining us. My name is Edward Nash and I'm a senior biotech analyst here at Canaccord Genuity. I'm joined by my colleague, Shinwe Ahn, who works on my team. We have the pleasure
- 4mo agoCRDLCardiol Therapeutics Reports Results of 2026 Annual General Meeting of ShareholdersPR NewswireTORONTO, June 25, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences...
- 4mo agoCRDLCardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on June 24th at 4:30 p.m. EDTPR NewswireTORONTO, June 23, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences...
- 6mo agoCRDLCardiol Therapeutics to Participate in Fireside Chat at H.C. Wainwright 4th Annual BioConnect Investor Conference at the NASDAQPR NewswireTORONTO, May 14, 2026 /PRNewswire/ - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a late-stage life sciences...
- 6mo agoCRDLCardiol Therapeutics' Phase II MAvERIC Results Accepted for Publication in the Journal of the American Heart AssociationPR NewswireResults demonstrate CardiolRx™ may represent a paradigm shift in the treatment of patients with recurrent pericarditis and further validate the...
- 6mo agoCRDLCardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal ProgramPR NewswireLeading enrolling centers include Cleveland Clinic, three major campuses of the Mayo Clinic, Northwestern University, Massachusetts General Hospital, ...
- 1y agoCRDLPRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRx™ Addressing Patients with Recurrent PericarditisGlobeNewswireCardiol Therapeutics President and CEO, David Elsley NEW YORK, Dec. 19, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView announces the release of an informative interview with Cardiol Therapeutics President and CEO,
- 1y agoCRDLCardiol Therapeutics Inc. Added to PRISM Emerging Biotech IndexGlobeNewswireNEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leading provider of market insights and company news, proudly announces that Cardiol Therapeutics Inc. (NASDAQ:CRDL, TSX:CRDL) has been added to the PRISM
- 4y agoADRAAEYEASRTAWH+1360+ Companies to Present at the 2nd Annual MicroCap Rodeo - Windy City Roundup Conference on October 12th - 13th, 2022 in ChicagoACCESS NewswireRALEIGH, NC / ACCESSWIRE / September 27, 2022 / The 2nd Annual MicroCap Rodeo Conference is going on the road and will take place at the Swissotel in Chicago on October 12th - 13th, 2022, where 60+ SmallCap, MicroCap and NanoCap public companies will be
- 4y agoBMYCRDLJNJNVO+1Hot Debate Over Myocarditis Risk Shines Spotlight on Heart DiseasePR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, Fla., July 26, 2022 /PRNewswire/ -- As COVID-19 vaccines for kids achieve the Centers for Disease Control and Prevention (CDC) recommendation, the concern that it could increase children's chances of m
- 4y agoAZNCRDLGSKREGNAir Pollution is a Global Heart and Lung Health ConcernPR NewswireFinancialNewsMedia.com News Commentary Palm Beach, FL, July 18, 2022 /PRNewswire/ -- Particulate matter or particle pollution is a significant contributor to heart and lung disease. Individuals most affected by poor air quality have asthma, chronic obs
- 4y agoCRDLNVSPODDVRNAThe Healthcare Companies Fighting the World's Biggest KillersPR NewswireFinancialNewsMedia.com News Commentary Palm Beach, Fla., July 13, 2022 /PRNewswire/ -- Some of the most prevalent health conditions on the planet claim millions of lives every year. Companies from across the healthcare sector are constantly innovating
- 4y agoCRDLMRKNTRATECHTackling Recurring Health Conditions Offers Hope to PatientsPR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, FL, June 21, 2022 /PRNewswire/ -- Being diagnosed with a health condition can often come as a shock but finding out it can recur is a double blow, particularly in the case of cancer or heart conditions
- 4y agoABTBMYCRDLNVO+1As Health Problems Mount Patients Welcome New TreatmentsPR NewswireFinancialNewsMedia.com News Commentary - PALM BEACH, Fla., June 14, 2022 /PRNewswire/ -- There are several serious health problems facing society today. Some, like heart disease, gastrointestinal diseases, cancer, and diabetes, pose a growing burden to
- 4y agoAZNCRDLGSKJNJ+1Breakthroughs In Treating Killer Diseases Could Lengthen LifePR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, Fla., June 7, 2022 /PRNewswire/ -- According to the World Health Organization, top global killers include heart failure, COPD, cancers, Alzheimer's, neonatal conditions, and diabetes. Therefore, discov
- 4y agoCRDLLLYNVOSNY+1Revolutionary Heart Therapy Offers Hope to Patients and Investors AlikePR NewswirePALM BEACH, Fla., May 31, 2022 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - Diabetes is a chronic health condition that occurs when your body's blood glucose, also called blood sugar, is too high. Blood sugar must be carefully regulated to e
- 4y agoADGCFBAUFFCRDLEWGFF+4Market Movers. Today's Top Stock Picks For New & Trending OpportunitiesACCESS NewswireMarket Movers. Today's Top Stock Picks For New & Trending Opportunities VANCOUVER, BC / ACCESSWIRE / May 27, 2022 / Investors want insight. Welcome to the Market Movers Newsletter where we have created a snapshot of new and trending companies that we th
- 4y agoABBVCRDLCRSPCYTKWhy Orphan Drug Designation Offers Several BenefitsPR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 18, 2022 /PRNewswire/ -- The U.S. FDA prioritizes developing new treatments for rare diseases with the ability to grant Orphan Drug Designation. Here we discuss the FDA's Orphan Drug Designa
- 4y agoCRDLLLYNVOSNYHeart Failure Treatment Offers Hope to DiabeticsPR NewswireFinancialNewsMedia.com News Commentary - PALM BEACH, Fla., May 11, 2022 /PRNewswire/ -- Diabetes and heart failure are closely linked. People with type 2 diabetes are two to four times more likely to develop heart failure than someone without diabetes